Content uploaded by Ricardo Vasconcellos
Author content
All content in this area was uploaded by Ricardo Vasconcellos on Jan 16, 2015
Content may be subject to copyright.
A preview of the PDF is not available
The use of psyllium to control constipation in dogs
Abstract
psyllium (Plantago psyllium) is a fiber generally used as a supplement in the treatment of diseases that led to constipation. To understanding of the effects of this fiber in dogs, two experiments were conducted. The first evaluated in healthy dogs a diet supplementation with 0%, 2% and 4% of ground whole psyllium seeds (as-fed basis). Eight adult Beagle dogs were used. They received the experimental diets for eight days. A linear increase of faecal moisture was verified with the addition of psyllium (R2=0.54 and P=0.0012), with no alteration on faecal score or number of defecations per day. The second experiment included 24 dogs with constipation. The dogs received a diet supplemented with 2% of psyllium as part of the treatment, and the owners were invited to answer a questionnaire. Nineteen (79.2%) owners reported that their dog had an easier defecation process during supplementation. Fifteen (62.5%) reported that the animals´ faeces, which were dry or hard at the start, became normal or pasty after psyllium consumption. The results confirmed a laxative effect of psyllium in dogs, which was already reported in human medicine, supporting the use of this fiber in the clinical management of diseases that cause constipation in dog.
... In dogs, higher dietary levels (≥ 5% in dry food) of cellulose (26,27), beet pulp (28,29) or psyllium seed (30,31) accelerate chyme passage and increase both feces volume and defecation frequency. The studies also showed that cellulose lowers water content of feces to a limited degree, whereas beet pulp and psyllium seed have a clear increasing effect. ...
... Including 6% psyllium in dry food accelerated gastric emptying and intestinal passage of chyme (34). Dry foods containing 2 or 4% ground psyllium seed increased volume and moisture content of dog feces (35). ...
... Psyllium seed showed low OMD (28.8%) but moderate gas (214 mL/g OM) and very high SCFA (41.24 Mmol/g OM) productions, and a particularly high proportion of butyrate (>5% of total SCFA). Psyllium gum has been widely used in veterinary medicine to prevent constipation, obesity and diabetes mellitus (Leib, 2000;Tortola et al., 2009). However, most petfood companies use ground psyllium seeds instead of psyllium gum because of their lower cost and greater availability. ...
Fermentable carbohydrates are an important part of the canine diet. They can improve gastrointestinal health by modifying gut microbial population and metabolic activity. The present study compared the fermentation characteristics and kinetic patterns of 10 carbohydrate sources using the in vitro gas production technique (IVGPT) with dog faecal inoculum. The substrates tested were: pure cellulose (PC), carboxymethylcellulose (CMC), sugar-cane fibre (SCF), beet pulp (BP), wheat bran (WB), fructooligosaccharides (FOS), inulin, yeast cell wall (YCW), ground psyllium seed (PS), pea hulls (PH). All substrates were incubated at 39°C under anaerobic conditions with faeces collected from dogs as microbial inoculum. Gas production of fermenting cultures was recorded and after 48 h, pH, short-chain fatty acids (SCFA) and organic matter disappearance (OMD) were determined. The results confirm high fermentation by dog faecal bacteria of FOS and inulin that produced high amounts of propionate and that underwent very rapid fermentation. Three substrates (SCF, CMC and PC) were not able to support bacterial growth, with low gas and SCFA production, and high BCFA formation. PH and BP showed moderate OMD and SCFA production. Wheat bran B underwent rapid fermentation and generated a high proportion of butyrate. PS underwent slow fermentation with delayed gas production, supporting a high formation of SCFA, with an adequate amount of butyrate for bacterial growth while YCW, which showed a delayed fermentation, gave moderate SCFA production. The fermentation characteristics of PS and YCW suggest their potential use in promoting a more distal fermentation on intestinal tract.
Scientific knowledge about companion animal nutrition has increased incrementally, following the phenomenon seen in several areas of knowledge. In the last decade may be the priority of research was directed to the use of nutrients in health promotion, prevention of degenerative diseases, improve quality of life and increased life expectancy of dogs and cats. This direction of research is largely explained by the importance that dogs and cats taken in people's lives, making that the decisions of the owners about the nutrition of their animals resembled those which adopt for themselves. The publication of the new revision of Nutrient Requirements of Dogs and Cats in 2006 was perhaps the most significant recent development, bringing new understanding of energy and nutrient needs at different developmental stages and physiological states. Despite these advances, further research is needed in the area of physical-chemical characterization and use of ingredients, effects of the extrusion process and even nutritional needs, which has a small base of available articles, many of them quite old. Perhaps the most important scientific challenge in nutrition of dogs and cats are carbohydrate metabolism, the importance of lean body mass in health, gerontology, the relationship between intestinal microbiota and health, immunonutrition and the nutritional management of important clinical conditions specific to these animals.
Two experiments were conducted to determine the viscosities of both soluble and insoluble dietary fibers. In Expt. 1, corn bran, defatted rice bran, guar gum, gum xanthan, oat bran, psyllium, soy hulls, stabilized rice bran, wheat bran, wood cellulose, and 2 methylcellulose controls (Ticacel 42, Ticacel 43) were hydrated in water overnight at 0.5, 1, 1.5, or 2% concentrations. In Expt. 2, guar gum, oat bran, psyllium, rice bran, wheat bran, and wood cellulose were subjected to a 2-stage in vitro gastric and small intestinal digestion simulation model. Viscosity was measured every 2 and 3 h during gastric and small intestinal simulation, respectively. Viscosities in both experiments were measured at multiple shear rates. Viscosities of all fiber solutions were concentration- and shear rate-dependent. Rice brans, soy hulls, and wood cellulose had the lowest viscosities, whereas guar gum, psyllium, and xanthan gum had the highest viscosities, regardless of concentration. During gastric simulation, viscosity was higher (P < 0.05) at 4 h than at 0 h for guar gum, psyllium, rice bran, and wheat bran. During small intestinal simulation, viscosities were higher (P < 0.05) between 3 and 9 h compared with 18 h for guar gum, oat bran, and rice bran. Guar gum, psyllium, and oat bran exhibited viscous characteristics throughout small intestinal simulation, indicating potential for these fibers to elicit blood glucose and lipid attenuation. Wheat and rice brans and wood cellulose did not exhibit viscous characteristics throughout small intestinal digestion; thus, they may be beneficial for laxation.
The effects of six extruded diets with different starch sources (cassava flour, brewer's rice, corn, sorghum, peas or lentils) on dog total tract apparent digestibility and glycemic and insulinemic response were investigated. The experiment was carried out on thirty-six dogs with six dogs per diet in a completely randomized design. The diets containing brewer's rice and cassava flour presented the greatest digestibility of dry matter, organic matter and gross energy (p < 0.05), followed by corn and sorghum; pea and lentil diets had the lowest. Starch digestibility was greater than 98% in all diets and was greater for brewer's rice and cassava flour than for lentils and peas diets (p < 0.05). Dogs' immediate post-prandial glucose and insulin responses (AUC < or = 30 min) were greater for brewer's rice, corn, and cassava flour diets (p < 0.05), and later meal responses (AUC > or = 30 min) were greater for sorghum, lentil and pea diets (p < 0.05). Variations in diet digestibility and post-prandial response can be explained by differences in chemical composition of each starch source including fibre content and starch granule structure. The nutritional particularities of each starch ingredient can be explored through diet formulations designed to modulate glycemic response. However, more studies are required to support these.
A series of experiments and evaluations of fractions isolated from psyllium seed husk (PSH) were used to test the overall hypothesis that a gel-forming component of PSH is not fermented and that it is this component that is responsible for the laxative and cholesterol-lowering properties of PSH. A gel is isolated from human stools collected during a controlled diet study when PSH is consumed but not when the control diet only is consumed. Evaluations of three fractions isolated from PSH suggest that gel-forming fraction B, which is about 55% of PSH, is poorly fermented and is the component that increases stool moisture and faecal bile acid excretion, the latter leading to lower blood cholesterol levels. Fraction C, representing < 15% of PSH, is viscous, but is rapidly fermented. Fraction A is alkali-insoluble material that is not fermented. In concentrations comparable with their presence in PSH, fractions A and C do not alter moisture and bile acid output. The active fraction of PSH is a highly-branched arabinoxylan consisting of a xylose backbone and arabinose- and xylose-containing side chains. In contrast to arabinoxylans in cereal grains that are extensively fermented, PSH possesses a structural feature, as yet unidentified, that hinders its fermentation by typical colonic microflora.
Constipation is common, and its treatment is unsatisfactory. Although many agents have been tried, there are limited data to support their use. Our aim was to undertake a systematic review of the efficacy and safety of traditional medical therapies for chronic constipation and to make evidence-based recommendations.
We searched the English literature for drug trials evaluating treatment of constipation by using MEDLINE and PUBMED databases from 1966 to 2003. Only studies that were randomized, conducted on adult subjects, and published as full manuscripts were included. Studies were assigned a quality score based on published methodology. Standard forms were used to abstract data regarding study design, duration, outcome measures, and adverse events. By using the cumulative evidence of published data for each agent, recommendations were made regarding their use following the United States Preventive Services Task Force guidelines.
Good evidence (Grade A) was found to support the use of polyethylene glycol (PEG) and tegaserod. Moderate evidence (Grade B) was found to support the use of psyllium, and lactulose. There was a paucity of quality data regarding many commonly used agents including milk of magnesia, senna, bisacodyl, and stool softeners.
There is good evidence to support the use of PEG, tegaserod, lactulose, and psyllium. Surprisingly, there is a paucity of trials for many commonly used agents. These aspects should be considered when designing trials comparing new agents with traditional therapies because their use may not be well validated.
There is no doubt that fibers, in particular viscous dietary fibers, have positive effects on human health, both in the prevention and in treatment of chronic diseases. Dietary fibers from psyllium have been used extensively both as pharmacological supplements, food ingredients, in processed food to aid weight control, to regulation of glucose control for diabetic patients and reducing serum lipid levels in hyperlipidemics. Keeping in view, the pharmacological importance of psyllium polysaccharide and its gel-forming nature, this article discusses the therapeutic value of psyllium for the treatment of constipation, diarrhea, irritable bowel syndrome, inflammatory bowel disease-ulcerative colitis, colon cancer, diabetes and hypercholesterolemia and exploitation of psyllium for developing drug delivery systems.
Constipation is a common gastrointestinal motility disorder that is often chronic, negatively affects patients' daily lives, and is associated with high healthcare costs. There is a considerable range of treatment modalities available for patients with constipation; however, the clinical evidence supporting their use varies widely. Nonpharmacologic modalities, such as increased exercise or fluid intake and bowel habit training, are generally recommended as first-line approaches, but data on the effectiveness of these measures are limited. The clinical benefits of various traditional pharmacologic agents (many of which are available over the counter, such as laxatives and fiber supplements) remain unclear. Although these modalities may benefit some patients with temporary constipation, their efficacy in patients for whom constipation is chronic is less well defined. Some studies suggest benefit with psyllium, polyethylene glycol, and lactulose; however, the use of other agents, such as calcium polycarbophil, methylcellulose, bran, magnesium hydroxide, and stimulant laxatives, is not supported by strong clinical evidence. More recently, newer agents have been approved for the treatment of patients with chronic constipation on the basis of comprehensive clinical investigation programs. Tegaserod, with its well-established clinical profile, and lubiprostone, the latest addition to the treatment armamentarium, represent the new generation of therapies for chronic constipation. This article reviews the efficacy and safety of traditional therapies used in the management of the multiple symptoms associated with chronic constipation and discusses recently approved and emerging therapies for this disorder.
The active fraction of psyllium seed husk
- J A Fischer
MARLETT, J.A.; FISCHER, M.H. The active fraction of
psyllium seed husk. Proccedings of the Nutrition Society,
v.62, n.1, p.207209, 2003.
Disponível em: <http://
p N u m
ber=&societyETOCSession=&fulltextType=MR&fileId=S0029665103000326>.
Acesso em: 02 set. 2009. doi: 10.1079/PNS2002201.